SART3/TIP110 Antibody

SART3 (squamous cell carcinoma antigen recognized by T cells 3) was identified as an antigenic peptide expressed in esophageal cancer cells that is recognized by cytotoxic T lymphocytes. Originally, in a search for a U6 small nuclear RNA capping enzyme, SART3 was identified as a 110kDa nuclear RNA-binding protein. Later, by database searching, SART 3 was determined to also be the human ortholog of the yeast Prp24 snRNP recycling factor that functions in the reassembly of the U4/U6 snRNP during the recycling phase of the splicesome cycle. Recently, SART3-derived peptides have been investigated as candidates for peptide-based immunotherapy in prostate cancer patients due to their ability to induce cytotoxic T lymphocyte activity against prostate cancer cells.
    Product/Catalog #SpecificationsPrice
    SART3/TIP110 Antibody
    A301-521A
    Reactivity: Human
    Applications: WB, IP, IHC-P, IF
    $314.00
    Bulk Quote
    Data Sheet
    Add to Cart
    SART3/TIP110 Antibody
    A301-522A
    Reactivity: Human
    Applications: WB, IP, IHC-P, IF
    $314.00
    Bulk Quote
    Data Sheet
    Add to Cart
    SART3/TIP110 Antibody AbVantage™ Pack
    A310-533A
    Applications: WB, IP, IHC-P, IF
    Reactivity: Human
    Quantity: 1 each of A301-521A and A301-522A
    $437.00
    Bulk Quote
    Data Sheet
    Add to Cart
    SART3/TIP110 IHC Antibody
    IHC-00294
    Applications: IHC-P, IF
    Reactivity: Human
    Quantity: 0.1 ml (50 - 250 slides)
    $360.00
    Bulk Quote
    Data Sheet
    Add to Cart
    Antibodies Manufactured onclick Site
    We Make Every Antibody
    We Sell.

    Please note that Cookies and JavaScript are required for you to view this website.

    Check if you have Cookies and JavaScript enabled in your browser